MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jjcc.2024.11.004

Медицинская библиотека · Journal of cardiology · 2024

Effect of tafamidis therapy on physical function in patients with wild-type transthyretin cardiac amyloidosis.

Shibata Atsushi, Izumiya Yasuhiro, Yoshida Toshitake, Tanihata Akiko, Kitada Ryoko, Otsuka Kenichiro, Ito Asahiro, Yamazaki Takanori, Fukuda Daiju

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Tafamidis is used as disease-modifying treatment for patients with wild-type transthyretin cardiac amyloidosis (ATTRwt CA). However, the effects of tafamidis on exercise tolerance are unclear.

METHODS

This single-center, prospective, observational study aimed to assess the effect of tafamidis on exercise tolerance in 36 patients with ATTRwt CA. Exercise tolerance was evaluated by the peak oxygen uptake (peak VO2) measured by the cardiopulmonary exercise test (CPX).

RESULTS

The baseline CPX showed a mean anaerobic threshold value of 11.6 ± 2.2 ml/kg/min and peak VO2 of 15.6 ± 4.1 ml/kg/min. Twenty-eight of the 36 patients underwent a follow-up CPX after 6 months. There was no significant change in peak VO2 before and 6 months after tafamidis therapy (16.0 ± 4.2 vs. 14.7 ± 4.0 ml/kg/min). The baseline CPX data showed that the mean peak VO2 was significantly lower in the increased peak VO2 group than in the non-increased peak VO2 group (13.7 ± 3.1 vs. 17.7 ± 4.1 ml/kg/min, p = 0.008). A multivariate logistic regression analysis showed that the baseline peak VO2 value was an independent predictor of improved exercise tolerance by tafamidis therapy (odds ratio: 0.646, 95 % confidence interval: 0.449-0.930, p = 0.019).

CONCLUSIONS

Tafamidis prevents deterioration of exercise tolerance in patients with ATTRwt CA. In some patients with ATTRwt CA, exercise tolerance may improve with the use of tafamidis, and those with lower exercise tolerance before tafamidis administration are likely to show improved exercise tolerance.

Для цитирования: Shibata Atsushi, Izumiya Yasuhiro, Yoshida Toshitake, Tanihata Akiko, Kitada Ryoko, Otsuka Kenichiro, Ito Asahiro, Yamazaki Takanori, Fukuda Daiju. Effect of tafamidis therapy on physical function in patients with wild-type transthyretin cardiac amyloidosis.. Journal of cardiology. 2024. DOI: 10.1016/j.jjcc.2024.11.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.